PharmaCielo Ltd.
PCLOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $27 | $25 | $143 |
| - Cash | $0 | $0 | $0 | $5 |
| + Debt | $21 | $18 | $13 | $8 |
| Enterprise Value | $34 | $46 | $37 | $146 |
| Revenue | $3 | $2 | $5 | $2 |
| % Growth | 125.7% | -71% | 172.9% | – |
| Gross Profit | $1 | -$1 | $1 | -$4 |
| % Margin | 21% | -88.8% | 12.8% | -221.5% |
| EBITDA | -$5 | -$12 | -$11 | -$25 |
| % Margin | -132.3% | -790.6% | -197.8% | -1,277.1% |
| Net Income | -$9 | -$16 | -$15 | -$27 |
| % Margin | -262.7% | -1,057.1% | -273.5% | -1,369.1% |
| EPS Diluted | -0.052 | -0.1 | -0.096 | -0.18 |
| % Growth | 47.8% | -4.1% | 46.6% | – |
| Operating Cash Flow | -$2 | -$5 | -$10 | -$20 |
| Capital Expenditures | $0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$2 | -$5 | -$10 | -$21 |